Efficacy and Safety of Long-Term Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis
Background Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is a standard therapy in patients with ischemic vascular diseases (IVD) including coronary artery, cerebrovascular and peripheral arterial diseases, although the optimal duration of this treatment is still debated. Previo...
Main Authors: | Xiaoming Zhang MD, Da Zhou PhD, Siying Song PhD, Xiangqian Huang MD, Yuchuan Ding PhD, Ran Meng MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-04-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296241244772 |
Similar Items
-
Update meta-analysis on the efficacy and safety issues of fexofenadine
by: René Maximiliano Gómez, MD, PhD, et al.
Published: (2023-07-01) -
Oral Anticoagulant and Antiplatelet
Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
by: Sheng-Lin Ye MD, et al.
Published: (2021-11-01) -
Prognostic Implications of Immature Platelet Fraction at 5-Year Follow-up Among ACS Patients Treated With Dual Antiplatelet Therapy
by: Karolina Gumiężna MD, et al.
Published: (2024-01-01) -
Efficacy and Safety of Huaier Granule as an Adjuvant Therapy for Cancer: An Overview of Systematic Reviews and Meta-Analyses
by: Jixin Chen MD, et al.
Published: (2022-03-01) -
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC
by: Alexander Drilon, MD, et al.
Published: (2022-06-01)